chrisvoncsefalvay/vaers-outcomes huggingface dataset:
suspected vaccination failure/lots of ppl that got Shingles from the vaccine; shingles/lots of ppl that got Shingles from the vaccine; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in an unspecified number of patients who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     Additional Information: GSK receipt date: 11-Jul-2022 Reporter's comment: The case was received from the consumer via interactive digital media. The reporter reported that the nurses caring for the patient told him/her that they know lots of people that got shingles from the vaccine. The reporter stated that yep so it was true.  The reporter stated that Shingles jabs will give shingles to people. Additional supportive information: This case was considered as suspected vaccination failure since the details regarding the completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles were unknown at the time of reporting. The follow-up could not be possible as no contact details were available. This was 1 of 3 cases reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2022AMR105986:same report, other patient US-GLAXOSMITHKLINE-US2022AMR106002:same report, other patient US-GLAXOSMITHKLINE-US2022AMR105986:same report, other patient
1/15/23 I started having vertigo. I can function, but it is nauseating and distracting. I still have it if I tip my head. I have never had Vertigo before. I saw my doctor who gave me exercises which have not stopped it. My eyesight doesn't seem to be as good. I saw an Ophthalmologist. My distance eyesight has declined, not as good as it was the last visit. I am also having headaches. TYLENOL will resolve. I have also experienced a lot of fatigue which is unexplained. I have tested multiple times for COVID and all tests have been negative.
Child was given DTaP instead of Tdap by mistake. Per package insert, the indication for DTaP is aged 6 weeks through 6 years, prior to 7th birthday, and this child was 7 years and 1 month old.
Nurse accidentally grabbed empty syringe and injected patient with .5 cc of air.  Pt was educated on what to expect such as welt/ arm soreness.  was told to notify doctor of increasing redness/ soreness that does not reside.
Patient summoned nurse over while waiting 10 minutes post-vaccination. Stated felt heart racing and like she was alternating getting hot/cold however skin was warm, pink and dry on palpation. Radial pulse 140 bpm. SpO2 100%. Stated she had a history of anxiety; nurse reassured and distracted her which helped symptoms initially but then symptom of heart racing returned accompanied by dry mouth and numbness of upper lip. Was transported in wheelchair to ED by RN.  Discharged from ED after 2 hour observation diagnosed as suspected anxiety attack; was instructed to follow-up with PCP and Employee Health regarding receipt of 2nd dose.
1 day later broke out in blisters-4 over arm/chest w/pink base, no fever, o/w well;
This spontaneous report as received from a healthcare worker refers to a patient of unknown age and unknown gender. On 29-MAY-2015, the patient was vaccinated with 0.5 ml of improperly stored (Oka/Merck) VARIVAX (lot # L001334 and expiry date 13-JAN-2017) once subcutaneously. NO adverse effects were reported. No product quality complaint was reported for (Oka/Merck) VARIVAX. This is one of the several reports from the same reporter. Additional information has been requested.
Initial report received from a healthcare professional on 05 December 2012. A 22-year-old female patient had received an intradermal second dose of FLUZONE intradermal vaccine (lot number UT4473AA) in left deltoid on 03 December 2012 at 12:45PM. Patient had no known allergies and illness at the time of vaccination, concomitant medications, adverse event following previous vaccination were none. The patient had received first dose of FLUZONE ID vaccine at age 12-year-old. On 03 December 2012 by 2 pm, the patient had first episode of diarrhea and the patient complained of low abdominal pain. The patient had no vomiting or nausea. Corrective treatments were not reported. Relevant diagnostic tests/laboratory data were none. At the time of this report, the outcome was unknown. Documents held by sender: none. Follow-up information received from a healthcare professional on 15 March 2013. The patient had received an intramuscular flu vaccine shot in her life at the age of 12. No medical treatment was given. The patient's outcome was recovered on 05 December 2012.
Facial paralysis; Herpes zoster; Hearing problems; Balance problems; Post herpetic neuralgia; This spontaneous report has been received from a lawyer referring to a female patient (pt) of unknown age. The pt's relevant medical history, drug reactions/allergies and concomitant medication were not reported. On an unknown date, the pt was vaccinated with zoster vaccine live (ZOSTAVAX) (dosage schedule, route of administration, anatomical location, lot number and expiration date were not reported) for routine health maintenance and for its intended purpose: the prevention of shingles. On unknown dates, after receiving zoster vaccine live (ZOSTAVAX), the pt experienced herpes zoster, facial paralysis, hearing problems, balance problems and post herpetic neuralgia. As a result of these symptoms, the pt was seen and treated by medical providers and was still under their care. As a direct and proximate result of pt's use of zoster vaccine live (ZOSTAVAX) vaccine, her symptoms had resulted in physical limitations not present prior. The pt also experienced mental and emotional distress due to resulting physical limitations and seriousness of her condition. The pt sustained severe, serious, progressive, incurable, and permanent personal injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. The outcome of the events was assessed as not recovered. The reporter considered all the events to be related to zoster vaccine live (ZOSTAVAX).   Upon internal review, the event of facial paralysis was determined to be medically significant, and all the events were considered as disabling due to "severe and permanent injuries".
FATIGUE; DIARRHEA; INJECTION SITE PAIN; LIGHT HEADEDNESS; This spontaneous report received from a patient concerned a 59 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included diabetic, iodine allergy, kiwi fruit skin allergy, non alcohol user, and smoker, and other pre-existing medical conditions included no drug abuse or illicit drug usage. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 043A21A, expiry: UNKNOWN) dose was not reported, administered on 09-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 09-APR-2021, the subject experienced light headedness. On 09-APR-2021, the subject experienced injection site pain. On 10-APR-2021, the subject experienced diarrhea. On 11-APR-2021, the subject experienced fatigue. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from light headedness on 09-APR-2021, and diarrhea on 11-APR-2021, was recovering from fatigue, and had not recovered from injection site pain. This report was non-serious.
Shingles like rash on both legs, inside near knee that has lasted two weeks.  Rx hydrocortisone calmed it down, but still visible.
Neck and facial hives with swelling.  Face was red and hot to tough. Benadryl taken-symptoms resolved by am
around 12 hours post vaccine: 105°F fever for 12 hours, neck and back stiffness for 4 days, fatigue- could not move without assistance, uncontrollable shaking, chills, soreness
Chills after first shot; This spontaneous case was reported by a physician and describes the occurrence of CHILLS (Chills after first shot) in an 81-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Jan-2021, the patient experienced CHILLS (Chills after first shot). On 21-Jan-2021, CHILLS (Chills after first shot) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant product use was reported  No treatment information was provided
Immediate injection site pain which continued for 2 weeks now. Exam indicates subacromial bursitis of right shoulder (vaccination arm). Treatment- subacromial corticosteroid injection 11/16/2023 given and home exercise packet.
Information has been received from a registered nurse (RN) concerning an infant who in August 2006 was vaccinated by mouth with the first dose of rotavirus G1 G2 G3 G4 P1 reassortant vaccine live (human-bovine) immediately after a feeding.  The RN reported that in August 2006, the patient vomited several times as the vaccine was given.  No other symptoms were noted.  It was unknown if medical attention was sought.  At the time of this report, the outcome was unknown.  Additional information has been requested.
Approximately at 10:36 a.m., pt reported light-headedness after COVID-19 vaccine. Pt was sitting in observation area accompanied by mother.  Pt slumped off chair, mother caught pt and laid him on floor. Pt quickly recovered and was A&O x 4. Pt did not hit head, though he reported a slight headache that resolved before he left premises at 11:05 a.m. Pt left walking with normal gait. Per mother, pt has history with prior vaccines & pt did not eat or drink prior to vaccinations that morning.  Mother was advised to call MD provider with any further concerns.
St, throat fullness, voice change, neck pain, color change of face, mild upper lip swelling.
Systemic: Tingling on the left arm-Mild, Systemic: Tingling (specify: facial area, extemities)-Mild, Additional Details: I gave patient a Cetirizine 10mg and an ice package as she complained of tingling on left arm. I monitored her for 35 minutes and she felt better and left. She said it happened after her second Moderna vaccine as well.
pt recv vax & devel swelling of the axillary lymph nodes;pt recovered 48hr;this is 1 of 6 pt from this site to have an adverse exp following vax w/lot# 6968173
HAD RAISED SKIN AT SITE OF INJECTION/   7 DAYS LATER HAD A LARGE RED MARK AT INJECTION SITE AND 102 FEVER CONSULTED MD GIVEN RX FOR AUGMENTIN
This is a spontaneous case, initially received from other health professional on 19-Oct-2018, concerning a 30-year-old, adult male patient. The patient had no relevant medical history. The patient was not taking any medication at the time of vaccination. On 09-Oct-2018, the patient was administered FLUCELVAX QIVc [dose: 1.5 ml instead of 0.5 ml, route of administration: intramuscular, anatomical location: left deltoid, batch number: 252235 and expiry date: 30-Jun-2019]. It was reported that the health care professional (HCP) followed up with the patient. At the time of this report, no adverse events were reported. This case is linked to 201804657 owing to same reporter. Significant case amendment (19-Oct-2018): The description to be coded for the verbatim "Received 1.5 ml dose instead of 0.5 ml' was changed from 'Extra dose administered' to 'Overdose'. The narrative and case comment were amended accordingly.
Guillain Barre; Also very painful; This serious case was reported by a consumer via interactive digital media and described the occurrence of guillain barre syndrome in an unspecified number of patients who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patients received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced guillain barre syndrome (Verbatim: Guillain Barre) (serious criteria GSK medically significant) and pain (Verbatim: Also very painful). The outcome of the guillain barre syndrome and pain were unknown.   It was unknown if the reporter considered the guillain barre syndrome and pain to be related to Shingles vaccine.     It was unknown if the company considered the guillain barre syndrome and pain to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 15-JUN-2023 This case was reported by a consumer via interactive digital media.  The reporter knew people have gotten Guillain Barre after getting the shot. Also very painful. The reporter wanted to know why get a shot that's not even keeping someone from still getting it.
Vaccine given 6 days post expiry; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine given 6 days post expiry) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 046C21A and 011J20A) for COVID-19 vaccination.     No Medical History information was reported.   On 29-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Nov-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine given 6 days post expiry). On 12-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Vaccine given 6 days post expiry) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The  concomitant medications on use were not provided. No treatment information was provided.  Patient did not had any adverse event.   This case was linked to MOD-2021-395985 (Patient Link).
This spontaneous report was received from an office manager and refers to an unspecified number of patients of unknown age and gender. No information regarding the patients' concurrent conditions, pertinent medical history, drug reaction, allergies and concomitant therapies was reported. On unknown dates, the patients received improperly stored doses of M-M-R II (doses and routes of administration were not provided) lot # M032485 (albumin status rHA), expiration date: 06-JUL-2018; lot # M032487 (albumin status recombinant human albumin (rHA)), expiration date: 05-JUL-2017. No adverse effects were reported. The vaccines were stored for 2 hours and 30 minutes in the temperature between 9 and 25 degrees Celsius. There were no previous temperature excursions. Digital Data Logger was involved. This is one of several reports received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1704USA013230: US-009507513-1704USA013231: US-009507513-1704USA013229: US-009507513-1704USA012451.
Recurring hives breakout all over body; Itching; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (Recurring hives breakout all over body) and PRURITUS (Itching) in a 35-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Seasonal allergy. Concomitant products included CETIRIZINE HYDROCHLORIDE (ZYRTEC ALLERGY) for Allergy.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Mar-2021, the patient experienced URTICARIA (Recurring hives breakout all over body) and PRURITUS (Itching). At the time of the report, URTICARIA (Recurring hives breakout all over body) and PRURITUS (Itching) outcome was unknown.            Treatment Benadryll, zyrtec, atarax, and doctor recently changed zyrtec to Claritin.
No adverse event; Past lot that had been expired, administered to patient; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Past lot that had been expired, administered to patient) and NO ADVERSE EVENT (No adverse event) in a 19-year-old male patient who received mRNA-1273 (Spikevax) (batch no. O70H21A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 12-Jul-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 12-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Past lot that had been expired, administered to patient). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Past lot that had been expired, administered to patient) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Past lot that had been expired, administered to patient).      Patient age was reported as 19 years and 03 months.  Concomitant product use was not provided by the reporter.  It was reported that patient were administered Moderna vaccine between 08-Apr-2022 and 15-Dec-2022.  Treatment information was not provided.
He got his vaccine, had an AE to prior Gardasil vaccine when he was 13-14 years of age in which he fainted and urinated on himself.  There was no reaction to the meningococcal in his right arm.  When he got the Gardasil vaccine mother could not look at his face, but the assistance was right there, and she said something to him and try to make him not think of the last time he had the reaction.  She had told her prior to the vaccine that they sit them in a chair for 15 minutes or so.  Mother states that he was not answering her, and she got up and got in front of him as well as the person giving him the shot, said he was OK, and then said that they had to sit him down as he was not sitting down, sat in the chair and asked if he was OK, said that he did not feel so good and then his eyes rolled back and his whole body was completely convulsing like you would see in a horror movie.   His veins were popping out of his neck, head was going all over, and trying to push on him to control him so he would not hurt himself.  He was seizing for 20 seconds or so, he yelled at them which is not his usual, kept calling his mother dude and to get off of him.  It took about 10-15 minutes to recover from the event.  He was supposed to have a meeting with a college counselor and pressed for time to get him back home, and they had to cancel that, did not go back to school and slept for the next day and a half (did eat, but then went back to sleep).   They told him at the clinic if things got worse during the night to go to the ER.  She has informed his pediatrician of the event, talked to one of the providers that was there as his is on vacation.  She talked to another dr. a day or so later and she sort of down-played it.  Said that they may not do the next vaccine.  He said that he had felt like he had a dream that he was on a rollercoaster.    He did inform her the next day that he was fatigued and very hot. He is a high honor student, 3 sport athlete and on no drugs or anything, he was fully health and then got the vaccine and had the grand mal seizure and it was horrifying to watch.  She is now afraid for him to get additional vaccines.
I ended up with Covid; had the first two vaccines and two booster from Pfizer (Unspecified Vaccine); I ended up with Covid; had the first two vaccines and two booster from Pfizer (Unspecified Vaccine); This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3 (booster), single (Batch/Lot number: unknown) and as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "I had bowel surgery" (unspecified if ongoing), notes: my bowel and I had bowel surgery (Intent: History) like major, it's 9 years ago. Concomitant medication(s) included: LINZESS. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "I ended up with Covid; had the first two vaccines and two booster from Pfizer (Unspecified Vaccine)". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Unknown Results. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical course: Patient stated that, ended up with Covid last week despite precautions and had the first two vaccines and two booster from Pfizer with no reactions whatsoever, and managed to all this time. So, patient was taking the Paxlovid and patient did not had high blood pressure but it felt like it was raising blood pressure. Patient had been trying Linzess from past couple of months although have not taken it from the past probably past 3 or so weeks because patient had been travelling and did not want to take it while travelling. Then the doctor knew this in backwards right now it's just experimental for patient because it gives diarrhea for sure so, patient was on the lowest dose of it and in fact were going to half the dose but patient had not taken it probably since the end of Jun because was going to travelling did not want to have that problem. Patient also drink some 'Prenz'  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Vaccine administered past the 10 week thaw date. 10 week thaw date was 4/21/23; vaccine administered 4/22/23
Near syncopal episode. Patient was layed down on cot and vital signs were taken and within normal limits.
PALSY OF THE RIGHT MOUTH FOR 2 DAYS (GONE); TREATED WITH ORAL STEROID RASH AT THE INJECTION SITE (STILL HAVE); TREATING WITH TOPICAL STEROID AND ITCH CREAM HEADACHE JOINT PAIN
10/18 has mosquito bites on each arm after injection site on upper arm, No temp noted scratching eased after 10/23, still has upset stomach.